Patents by Inventor Jane E. Bailly

Jane E. Bailly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
    Patent number: 7632508
    Abstract: Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an immune response to PIV or other pathogens. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete human or bovine PIV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different PIV. Chimeric human-bovine PIV of the invention include a partial or complete “background” PIV genome or antigenome derived from or patterned after a human or bovine PIV virus combined with one or more heterologous gene(s) or genome segment(s) of a different pathogen, including different PIV virus to form the human-bovine chimeric PIV genome or antigenome.
    Type: Grant
    Filed: January 4, 2006
    Date of Patent: December 15, 2009
    Assignee: The United States of America
    Inventors: Alexander C. Schmidt, Mario H. Skiadopoulos, Peter L. Collins, Brian R. Murphy, Jane E. Bailly, Anna P. Durbin
  • Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
    Patent number: 7201907
    Abstract: Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an anti-PIV immune response or as vectors for introducing heterologous genes into a host. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete human or bovine PIV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different PIV. Chimeric human-bovine PIV of the invention include a partial or complete “background” PIV genome or antigenome derived from or patterned after a human or bovine PIV virus combined with one or more heterologous gene(s) or genome segment(s) of a different PIV virus to form the human-bovine chimeric PIV genome or antigenome.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: April 10, 2007
    Assignee: The United States of America, Represented by the Secretary, Department of Health and Human Services
    Inventors: Alexander C. Schmidt, Mario H. Skiadopoulos, Peter L. Collins, Brian R. Murphy, Jane E. Bailly, Anna P. Durbin